- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06248151
Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-COVID-19 Syndrome (ExPostCovid-19)
December 3, 2024 updated by: Raphael Mendes Ritti Dias, University of Nove de Julho
Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-Covid-19 Syndrome
The objective of the study is to compare the acute cardiorespiratory and perceptual responses to a physical exercise session in those infected by Covid-19 with and without persistent symptoms.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will be a crossover carried out in two groups (with and without persistent symptoms of Covid-19).
Participants in both groups will undergo a control session and an exercise session and cardiorespiratory and perceptual responses will be obtained before, during and after the sessions.
In the exercise session, participants will perform aerobic exercises, strength exercises and muscle stretching, while in the control session participants will remain seated.
Blood pressure, heart rate, cardiac autonomic modulation, peripheral oxygen saturation, vascular function and perception of affect will be obtained.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Raphael Dias, PhD
- Phone Number: +5519999406878
- Email: raphaelritti@gmail.com
Study Contact Backup
- Name: Marilia Correia, PhD
- Phone Number: +5511999711669
- Email: marilia.correia@live.com
Study Locations
-
-
-
São Paulo, Brazil, 01504-001
- Recruiting
- Universidade Nove de Julho
-
Contact:
- Raphael Dias
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Post-Covid Syndrome group:
- have had a positive RT-PCR test for Covid-19;
- present persistent symptoms of Post Covid 19 syndrome, which have no other health explanation according to the criteria of the World Health Organization (WHO);
- have the cognitive and physical capacity to perform the exercises; It is
- low cardiovascular risk classification according to the American College of Sports Medicine criteria.
Healthy group:
- not present persistent symptoms of Post Covid 19 syndrome, which have no other health explanation according to the criteria of the World Health Organization (WHO);
- have the cognitive and physical capacity to perform the exercises; It is
- low cardiovascular risk classification according to the American College of Sports Medicine criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise
In the exercise session, participants will perform aerobic, free active and flexibility exercises and will last approximately 45 minutes.
|
Session will included aerobic, resistance and flexibility exercises and will last approximately 45 minutes.
The session will begin with aerobic exercises (5 min jumping jacks and 5 min stationary walking).
Then, nine strength exercises will be performed for the main muscle groups (3 times of 12 to 15 repetitions, with a 1-minute rest interval) and finally stretching for the main muscle groups
Other Names:
Remain seated for 60 min
|
|
Other: Control
In the control session, participants will remain seated for 60 minutes.
|
Session will included aerobic, resistance and flexibility exercises and will last approximately 45 minutes.
The session will begin with aerobic exercises (5 min jumping jacks and 5 min stationary walking).
Then, nine strength exercises will be performed for the main muscle groups (3 times of 12 to 15 repetitions, with a 1-minute rest interval) and finally stretching for the main muscle groups
Other Names:
Remain seated for 60 min
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Blood pressure
Time Frame: Before and 30 and 50 minutes after the end of the exercise and control interventions
|
Assessment of the systolic and diastolic blood pressure using an automatic device
|
Before and 30 and 50 minutes after the end of the exercise and control interventions
|
|
Change in Heart rate variability
Time Frame: Before and 30 and 50 minutes after the end of the exercise and control interventions
|
Assessment of the heart rate variability indicators using a heart rate monitor
|
Before and 30 and 50 minutes after the end of the exercise and control interventions
|
|
Change in flow mediated dilation
Time Frame: Before and 30 minutes after the end of the exercise and control interventions
|
Assessment of the flow mediated dilation using a doppler ultrasound
|
Before and 30 minutes after the end of the exercise and control interventions
|
|
Change in peak exhalation flow
Time Frame: Before and 5 minutes after the end of the exercise and control interventions
|
Assessment of the peak exhalation flow using a peak flow device
|
Before and 5 minutes after the end of the exercise and control interventions
|
|
Change in oxygen saturation
Time Frame: Before, during and 5 minutes after the end of the exercise and control interventions
|
Assessment of the peripheral oxygen saturation using a pulse oximeter
|
Before, during and 5 minutes after the end of the exercise and control interventions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in heart rate
Time Frame: Before and continuously during exercise and control interventions
|
Assessment of heart rate using a heart rate monitor
|
Before and continuously during exercise and control interventions
|
|
Change in affective response
Time Frame: Before and every 5 minutes during exercise and control interventions
|
Assessment of affective response using a felling scale
|
Before and every 5 minutes during exercise and control interventions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Raphael Dias, PhD, University of Nove de Julho
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2024
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
July 30, 2025
Study Registration Dates
First Submitted
February 6, 2024
First Submitted That Met QC Criteria
February 6, 2024
First Posted (Actual)
February 8, 2024
Study Record Updates
Last Update Posted (Estimated)
December 4, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Post-Infectious Disorders
- Pathologic Processes
- Chronic Disease
- Disease Attributes
- Respiratory Tract Infections
- Infections
- RNA Virus Infections
- Virus Diseases
- Respiratory Tract Diseases
- Disease
- Lung Diseases
- Pneumonia, Viral
- Pneumonia
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- COVID-19
- Post-Acute COVID-19 Syndrome
- Syndrome
Other Study ID Numbers
- Acute_Covid
- 0057/2022 (Other Identifier: CAPES)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Plan to share the data after completion upon resonable request
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Acute COVID-19 Syndrome
-
Jonathann Kuo, MDCompletedSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
RSUP PersahabatanCompletedPost COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID Syndrome Long CovidIndonesia
-
Azienda Socio Sanitaria Territoriale di LeccoRecruitingPost Acute COVID-19 SyndromeItaly
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
Massachusetts General HospitalBoston Children's Hospital, Boston, MA, USAActive, not recruitingPost Acute COVID-19 Syndrome | Long COVID | Post Acute Sequelae of COVID-19 | Long COVID-19United States
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Leiden University Medical CenterUniversity Medical Center Groningen; UMC Utrecht; Academisch Medisch Centrum... and other collaboratorsRecruitingCOVID-19 | Post-Acute COVID19 Syndrome | Post-COVID-19 Syndrome | Post-Acute COVID-19 | Post COVID-19 Condition | Multi-System Inflammatory Syndrome in Children | Pediatric Inflammatory Multisystem SyndromeNetherlands
-
Adhera Health, Inc.Institut Català de la Salut; Andaluz Health ServiceCompletedFatigue | Post-Acute COVID19 SyndromeSpain
Clinical Trials on Exercise session
-
University of MichiganCompletedCellular Responses Within Skeletal Muscle in Response to Exercise of Different Intensities | Relationship Between the Cellular Responses in Skeletal Muscle and the Changes in the Metabolomic Profile | Changes Within Adipose Tissue in Response to Exercise at the Three Different IntensitiesUnited States
-
Instituto de Cardiologia do Rio Grande do SulCompletedCardiac Rehabilitation | Aerobic Exercise | Resistance ExerciseBrazil
-
USDA Beltsville Human Nutrition Research CenterUnited States Army Research Institute of Environmental MedicineCompleted
-
Hospital de Clinicas de Porto AlegreUnknownType 1 Diabetes MellitusBrazil
-
The University of Tennessee, KnoxvilleCompletedActive Lifestyle Males | Inactive Lifestyle MalesUnited States
-
Herlev and Gentofte HospitalUniversity of CopenhagenCompletedMalignant Melanoma | Cancer of Cervix | Cancer of the Prostate | Cancer, Ovarian | Lymphedema of Leg | Cancer, EndometrialDenmark
-
University of PoitiersCompletedMenopause | Blood Pressure | Cognitive DeclineFrance
-
Instituto de Cardiologia do Rio Grande do SulCompleted
-
University of MichiganCompleted
-
University of MichiganCompleted